Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE7A | Q13946 | 4/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | KDM4A | O75164 | 1/20 | 0.49 |
| ▸ | TDP2 | O95551 | 1/20 | 0.49 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.49 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL4852221 | 0.89 | MAPT (0.50) | PDE7ASMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL31272173 | 0.82 | PDE7A (0.78) | PDE7ASMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL875772 | 0.82 | PDE7A (0.78) | PDE7ASMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL224666 | 0.82 | PDE7A (0.60) | PDE7ASMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL944057 | 0.82 | TSHR (0.53) | PDE7ASMN1; SMN2ALDH1A1TSHRHSD17B10 | |
| SCHEMBL1967695 | 0.82 | TDP1 (0.47) | PDE7ASMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL3384869 | 0.80 | PDE7A (0.58) | PDE7ASMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL1896221 | 0.80 | PDE7A (0.58) | PDE7ASMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL113566 | 0.78 | PDE7A (0.61) | PDE7ASMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL2458682 | 0.78 | PDE7A (0.56) | PDE7ASMN1; SMN2MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 668 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008007807-A1 | DIAGNOSTIC BIOMOLECULES | SHIMADZU CORPORATION (JP) | 2008-01-17 | — | — | WO | claimed |
| EP-1700114-A4 | METHOD FOR ENRICHMENT/SEPARATION OF PROTEIN OR PEPTIDE | SHIMADZU CORP (JP) | 2007-07-11 | — | — | EP | claimed |
| US-20070112181-A1 | Method for enrichment/seperation of protein or peptide | SHIMADZU CORPORATION (JP) | 2007-05-17 | — | — | US | claimed |
| EP-1739419-A1 | METHOD OF MEASURING SUBSTANCE BY MASS SPECTROMETRY AND KIT THEREFOR | SHIMADZU CORPORATION (JP) | 2007-01-03 | — | — | EP | claimed |
| US-20060243899-A1 | Method for selective measurement of specific substances from a mixture by maldi mass spectrometry | SHIMADZU CORPORATION | 2006-11-02 | — | — | US | claimed |
| EP-1700114-A2 | METHOD FOR ENRICHMENT/SEPARATION OF PROTEIN OR PEPTIDE | SHIMADZU CORPORATION (JP) | 2006-09-13 | — | — | EP | claimed |
| US-20050224710-A1 | Method for measuring hydrophobic peptides using maldi mass spectrometer | SHIMADZU CORPORATION (JP) | 2005-10-13 | — | — | US | claimed |
| WO-2005062725-A2 | METHOD FOR ENRICHMENT/SEPARATION OF PROTEIN OR PEPTIDE | SHIMADZU CORPORATION (JP) | 2005-07-14 | — | — | WO | claimed |
| EP-0646013-A4 | PLATELET DERIVED GROWTH FACTOR ANTAGONISTS. | LUDWIG INST CANCER RES (US) | 1997-10-15 | — | — | EP | claimed |
| US-5444151-A | Polypeptides containing modified tryptophan units | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1995-08-22 | — | — | US | claimed |
| EP-0646013-A1 | PLATELET DERIVED GROWTH FACTOR ANTAGONISTS | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1995-04-05 | — | — | EP | claimed |
| WO-1993023068-A1 | PLATELET DERIVED GROWTH FACTOR ANTAGONISTS | LUDWIG INSTITUTE FOR CANCER RESEARCH (US) | 1993-11-25 | — | — | WO | claimed |
| EP-0301376-A1 | Rubber vulcanisation process using a vulcanisation system based on 2-nitrophenyl sulphenamides, 2-nitrophenyl sulphenamides, and their preparation | BAYER AG (DE) | 1989-02-01 | — | — | EP | claimed |
| US-12613133-B2 | Inspection tool and inspection method | FUJIFILM CORPORATION (JP) | 2026-04-28 | — | — | US | disclosed |
| US-12436096-B2 | Ultraviolet inspection tool and inspection method using a visual indicator | FUJIFILM CORPORATION (JP) | 2025-10-07 | — | — | US | disclosed |
| US-12372397-B2 | Ultraviolet-sensing member, microcapsule, production method of microcapsule, dispersion liquid for forming ultraviolet-sensing layer, and ultraviolet-sensing kit | FUJIFILM CORPORATION (JP) | 2025-07-29 | — | — | US | disclosed |
| US-3993646-A | Process for the ring expansion of penicillins to cephalosporin compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-11-23 | — | — | US | disclosed |
| US-3954744-A | ANTIBACTERIAL | E. R. SQUIBB & SONS, INC. (US) | 1976-05-04 | — | — | US | disclosed |
| US-3932391-A | Cephalosporin isocyanates | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-01-13 | — | — | US | disclosed |
| US-3931235-A | FROM THE ALKALIMETAL SALT OF 4-HYDROXY-6-METHYL-2-PYRONE AND A THIOLSULFONATE | THE DOW CHEMICAL COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12613133-B2 | Inspection tool and inspection method | TAS2R30, TAS2R60, TAS2R39 | PDE7A 4885/4885SMN1; SMN2 592/4885MAPT 1113/4885 |
| US-20070112181-A1 | Method for enrichment/seperation of protein or peptide | PTMS, MAX, PREP | PDE7A 4415/4885SMN1; SMN2 2607/4885MAPT 2490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.